Workflow
Jin Rong Jie
icon
Search documents
三祥新材股价下跌2.11% 固态电池概念受关注
Jin Rong Jie· 2025-08-26 20:03
从资金流向来看,8月26日主力资金净流入437.92万元,但近五个交易日整体呈现净流出状态,累计净 流出1812.30万元。 风险提示:股市有风险,投资需谨慎。 三祥新材8月26日股价报收27.79元,较前一交易日下跌0.60元,跌幅2.11%。当日成交量为12.63万手, 成交金额达3.52亿元。 该公司主营业务为锆系新材料、镁铝合金等产品的研发、生产和销售。产品广泛应用于建筑陶瓷、汽车 零部件、电子电器等领域。作为福建地区的重要新材料企业,三祥新材在固态电池材料领域有所布局。 ...
卧龙新能股价下跌1.67% 控股股东解除质押3000万股
Jin Rong Jie· 2025-08-26 20:03
资金流向方面,8月26日主力资金净流出406.53万元,占流通市值0.09%。近五个交易日主力资金累计净 流入677.72万元。 风险提示:以上内容仅供参考,不构成投资建议。股市有风险,投资需谨慎。 公司控股股东浙江卧龙置业投资有限公司于8月25日解除质押3000万股无限售流通股。本次解质后,该 股东累计质押股份占其持股比例为9.55%,占公司总股本4.28%。 截至8月26日收盘,卧龙新能股价报6.46元,较前一交易日下跌0.11元。当日成交量为12.63万手,成交 金额达0.82亿元。 卧龙新能主营业务为房地产开发,同时涉及储能、氢能源、风能等新能源领域。公司总市值45.25亿 元,市盈率为27.75倍。 ...
新瀚新材股价下跌5.09% 半年度净利润同比增长20.4%
Jin Rong Jie· 2025-08-26 20:03
Group 1 - The stock price of Xinhan New Materials is reported at 51.66 yuan, down by 2.77 yuan from the previous trading day, with an opening price of 54.98 yuan, a high of 54.99 yuan, and a low of 51.50 yuan, with a trading volume of 174,000 hands and a transaction amount of 911 million yuan [1] - Xinhan New Materials specializes in the research, production, and sales of aromatic ketone products, operating within the chemical raw materials sector [1] - The company disclosed its semi-annual report for 2025, showing a revenue of 229 million yuan for the first half of the year, representing a year-on-year growth of 9.66%, and a net profit attributable to shareholders of 35.29 million yuan, reflecting a year-on-year increase of 20.40% [1] Group 2 - The company plans to distribute a cash dividend of 1 yuan for every 10 shares to all shareholders [1] - On August 26, the company received visits from several institutions, including Jiashi Fund and Donghai Fund, for research purposes [1] - On August 26, the net outflow of main funds was 154.23 million yuan, with a cumulative net outflow of 406.47 million yuan over the past five days [1]
雪榕生物股价小幅下跌 上半年亏损1.03亿元
Jin Rong Jie· 2025-08-26 20:03
Core Viewpoint - Xuerong Bio's stock price closed at 6.73 yuan on August 26, down 1.03% from the previous trading day, with a trading volume of 150,942 hands and a transaction amount of 102 million yuan [1] Company Overview - The company specializes in the research, production, and sales of edible mushrooms, with main products including enoki mushrooms and king oyster mushrooms [1] - Xuerong Bio operates within the agriculture, animal husbandry, and fishery industry, and is also involved in agricultural planting and plant-based meat sectors [1] Financial Performance - In the first half of 2025, the company reported operating revenue of 791 million yuan, a year-on-year decrease of 26.17% [1] - The net profit attributable to the parent company was a loss of 103 million yuan [1] Capital Flow - On August 26, the net outflow of main funds was 7.4632 million yuan, with a cumulative net outflow of 21.9462 million yuan over the past five days [1]
昂利康股价震荡下行 盘中振幅超11%
Jin Rong Jie· 2025-08-26 20:03
从资金流向来看,8月26日主力资金净流出5809.46万元,占流通市值的0.59%。不过近五个交易日整体 呈现净流入状态,累计净流入5533.16万元。 该公司属于化学制药板块,主营业务为医药产品的研发、生产和销售。作为浙江地区的医药企业,昂利 康在合成生物和创新药领域有所布局。 风险提示:股市有风险,投资需谨慎。 昂利康8月26日股价呈现震荡走势,最终收于52.88元,较前一交易日下跌4.93%。盘中最高触及58.93 元,最低下探52.69元,振幅达11.22%。当日成交量为19.1万手,成交金额10.55亿元。 ...
大为股份股价回落至18.75元 盘中曾快速反弹超2%
Jin Rong Jie· 2025-08-26 20:03
Group 1 - The stock price of Dawi Co., Ltd. closed at 18.75 yuan on August 26, 2025, down 1.99% from the previous trading day [1] - The trading volume on that day reached 486 million yuan, with a turnover rate of 12.46% [1] - During the trading session, the stock experienced a rapid rebound, with a peak increase of over 2% at 9:38 AM, reaching a maximum price of 19.42 yuan [1] Group 2 - Dawi Co., Ltd. operates in the semiconductor industry and is also involved in lithium mining and storage chip sectors [1] - The company is registered in Guangdong Province, with a total market capitalization of approximately 4.45 billion yuan [1] - On August 26, the net outflow of main funds was 56.6851 million yuan, with a cumulative net outflow of 151 million yuan over the past five trading days [1]
茂莱光学股价下跌5.33%,科创板百元股数量达63只
Jin Rong Jie· 2025-08-26 20:03
Group 1 - The stock price of Maolai Optical closed at 427.00 yuan on August 26, 2025, down 24.02 yuan from the previous trading day, representing a decline of 5.33% [1] - The opening price for the day was 442.00 yuan, with a highest price of 446.00 yuan and a lowest price of 420.10 yuan, with a trading volume of 13,354 lots and a transaction amount of 578 million yuan [1] - Maolai Optical is part of the optical optoelectronics industry, focusing on the research and production of precision optical components, which are widely used in consumer electronics and medical devices [1] Group 2 - There are 63 stocks priced over 100 yuan on the Sci-Tech Innovation Board, with Maolai Optical ranking second in the latest closing price, only behind Cambricon [1] - On that day, the net outflow of main funds for Maolai Optical was 51.88 million yuan, with a cumulative net outflow of 30.40 million yuan over the past five days [1]
哈森股份股价下跌2.71% 上半年营收同比增长67%
Jin Rong Jie· 2025-08-26 20:03
Core Viewpoint - The stock price of Hason Co., Ltd. has decreased by 2.71% as of August 26, 2025, reflecting market volatility and investor sentiment towards the company's recent performance and strategic acquisitions [1] Financial Performance - In the first half of 2025, Hason Co., Ltd. achieved a revenue of 699 million yuan, representing a year-on-year growth of 67.03% [1] - The company reported a net loss attributable to shareholders of 1.71 million yuan, which is an improvement of 10.14 million yuan compared to the same period last year [1] - Revenue from the metal structure components business amounted to 293 million yuan, accounting for 42.71% of total revenue [1] - Revenue from automation equipment and fixtures reached 40.35 million yuan, contributing 5.89% to total revenue [1] Strategic Acquisitions - In the first half of 2025, the company completed the acquisition of 55.2% of Hason Industrial and 45% of Suzhou Langkes, expanding its business into precision metal structure components and related equipment [1] - Subsidiaries Suzhou Langkes and Hason Industrial have passed supplier evaluations by Apple’s supply chain manufacturers, indicating potential for future growth and partnerships [1] Market Activity - As of August 26, 2025, the stock experienced a net outflow of 18.36 million yuan from major funds, representing 0.48% of the circulating market value [1] - Over the past five days, the net outflow from major funds totaled 20.33 million yuan, accounting for 0.53% of the circulating market value [1]
翔鹭钨业股价下探4.53% 盘中快速反弹成交额超9亿元
Jin Rong Jie· 2025-08-26 20:03
Company Overview - Xianglu Tungsten Industry's stock price closed at 11.58 yuan on August 26, 2025, down 0.55 yuan, a decrease of 4.53% from the previous trading day [1] - The stock reached a low of 11.12 yuan and a high of 11.90 yuan during the day, with a total trading volume of 9.04 billion yuan and a turnover rate of 29.53% [1] - The company specializes in the research, production, and sales of tungsten products, including tungsten powder, hard alloys, and other tungsten products, which are widely used in mechanical processing, mining, and electronics industries [1] Market Activity - On August 26, the stock experienced a quick rebound, with an increase of over 2% within 5 minutes, reaching 11.59 yuan by 13:06, with a trading volume of 6.04 billion yuan [1] - The net inflow of main funds into Xianglu Tungsten Industry on that day was 8.175 million yuan, with a cumulative net inflow of 106 million yuan over the past five days [1]
仟源医药股价下跌4.48% 上半年净利润同比下滑98.86%
Jin Rong Jie· 2025-08-26 20:03
Group 1 - The stock price of Qianyuan Pharmaceutical on August 26 was 11.51 yuan, down 0.54 yuan or 4.48% from the previous trading day [1] - The company operates in the chemical pharmaceutical sector, focusing on the research, production, and sales of pharmaceuticals and health foods, as well as medical diagnostics and genetic preservation services [1] - In the first half of 2025, the company reported revenue of 373 million yuan, a year-on-year decrease of 7.01%, and a net profit attributable to shareholders of 380,900 yuan, down 98.86% year-on-year [1] Group 2 - The company's net loss from non-recurring items was 5.01 million yuan, primarily due to the impact of a subsidiary's payment of corporate income tax and late fees [1] - On August 26, the net outflow of main funds for Qianyuan Pharmaceutical was 57.33 million yuan, accounting for 2.19% of the circulating market value [1] - Over the past five days, the net outflow of main funds totaled 128.93 million yuan, representing 4.93% of the circulating market value [1]